Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2372297
Max Phase: Preclinical
Molecular Formula: C52H76N14O12S2
Molecular Weight: 1153.40
Molecule Type: Unknown
Associated Items:
ID: ALA2372297
Max Phase: Preclinical
Molecular Formula: C52H76N14O12S2
Molecular Weight: 1153.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOc1ccc(C[C@@H]2NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1
Standard InChI: InChI=1S/C52H76N14O12S2/c1-4-52(5-2)27-43(70)60-35(25-31-16-18-32(19-17-31)78-6-3)46(73)63-36(24-30-12-8-7-9-13-30)47(74)61-34(20-21-40(53)67)45(72)64-37(26-41(54)68)48(75)65-38(29-79-80-52)50(77)66-23-11-15-39(66)49(76)62-33(14-10-22-58-51(56)57)44(71)59-28-42(55)69/h7-9,12-13,16-19,33-39H,4-6,10-11,14-15,20-29H2,1-3H3,(H2,53,67)(H2,54,68)(H2,55,69)(H,59,71)(H,60,70)(H,61,74)(H,62,76)(H,63,73)(H,64,72)(H,65,75)(H4,56,57,58)/t33-,34+,35+,36+,37+,38+,39+/m1/s1
Standard InChI Key: JDPBWPNOTVHKBY-XMDRUOKISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1153.40 | Molecular Weight (Monoisotopic): 1152.5209 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Manning M, Lammek B, Bankowski K, Seto J, Sawyer WH.. (1985) Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin., 28 (10): [PMID:4045923] [10.1021/jm00148a019] |
Source(1):